Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder

International Journal of Neuropsychopharmacology

Volumn 12, Issue 9, 2009, Pages 1291-1293

  Lai, Chien Han ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; PAROXETINE; RISPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADOLESCENT; BLINKING; CASE REPORT; CHRONIC DISEASE; DIZZINESS; DRUG DOSE TITRATION; DRUG RESISTANCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; MOTOR DYSFUNCTION; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SELF ESTEEM; THERAPY RESISTANCE; TIC; CHEMICALLY INDUCED DISORDER; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; DIZZINESS; DOPAMINE AGENTS; DRUG RESISTANCE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES; TIC DISORDERS; TREATMENT OUTCOME;

EID: 79958115158     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709990393     Document Type: Letter

References (14)

1. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, et al. (2006). A systematic review: antipsychotic augmentation with treatment refractory obsessivecompulsive disorder. Molecular Psychiatry 11, 622-632 (Pubitemid 43989810)
2. Budman C, Coffey BJ, Shechter R, Schrock M, et al. (2008). Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts. Journal of Child and Adolescent Psychopharmacology 18, 509-515
3. Gao K, Muzina D, Gajwani P, Calabrese JR (2006). Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. Journal of Clinical Psychiatry 67, 1327-1340 (Pubitemid 44583379)
4. Giorgetti M, Tecott LH (2004). Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems. European Journal of Pharmacology 488, 1-9 (Pubitemid 38388517)
5. Henderson DC (2008). Managing weight gain and metabolic issues in patients treated with atypical antipsychotics. Journal of Clinical Psychiatry 69, e04
6. Hershey T, Black KJ, Hartlein JM, Barch DM, et al. (2004). Cognitive-pharmacologic functional magnetic resonance imaging in Tourette syndrome: a pilot study. Biological Psychiatry 55, 916-925 (Pubitemid 38526304)
7. Horacek J, Bubenikova-Valesova V, Kopecek M, Palenicek T, et al. (2006). Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs 20, 389-409 (Pubitemid 43763739)
8. Lawler CP, Prioleau C, Lewis MM, Mak C, et al. (1999). Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 20, 612-627 (Pubitemid 29189265)
9. Olver JS, O'Keefe G, Jones GR, Burrows GD, et al. (2008). Dopamine D(1) receptor binding in the striatum of patients with obsessive-compulsive disorder. Journal of Affective Disorders 114, 321-326
10. Pae CU, Serretti A, Patkar AA, Masand PS (2008). Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence. CNS Drugs 22, 367-388 (Pubitemid 351508122)
11. Perani D, Garibotto V, Gorini A, Moresco RM, et al. (2008). In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage 42, 306-314
12. Winter C, Heinz A, Kupsch A, Strohle A (2008). Aripiprazole in a case presenting with tourette syndrome and obsessive-compulsive disorder. Journal of Clinical Psychopharmacology 28, 452-454
13. Yokoi F, Grunder G, Biziere K, Stephane M, et al. (2002). Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Neuropsychopharmacology 27, 248-259 (Pubitemid 34692591)
14. Yoo HK, Choi SH, Park S, Wang HR, et al. (2007). An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders. Journal of Clinical Psychiatry 68, 1088-1093 (Pubitemid 47340331)